Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-18 · accession 0000899243-22-015145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-20 | 2022-04-18+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $3.27 | +300.0K | 4.29M | +8% | +$979.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | P | A | 150,000 | $3.29 | 4,138,402 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-19 | P | A | 150,000 | $3.24 | 4,288,402 | D | — | — |